Caribou Biosciences, Inc. (CRBU) Return on equity 2019–2025
Caribou Biosciences, Inc. (CRBU) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-121.2%FY2025 · since FY2019: -314.0% → -121.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -121.2% | -62.3 pp |
| FY2024 | -58.9% | -31.2 pp |
| FY2023 | -27.7% | +5.3 pp |
| FY2022 | -33.0% | -15.8 pp |
| FY2021 | -17.3% | — |
| FY2019 | -314.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CRBU financial trends
CRBU RevenueCRBU Net incomeCRBU Net marginCRBU Gross profitCRBU Gross marginCRBU Operating incomeCRBU Operating marginCRBU Operating cash flowCRBU Free cash flowCRBU Capital expendituresCRBU Stock buybacksCRBU Dividends paidCRBU Total assetsCRBU Total liabilitiesCRBU Shareholders’ equityCRBU overview →